NDC 69102-319

SUBVENITE

Lamotrigine

SUBVENITE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Owp Pharmaceuticals, Inc.. The primary component is Lamotrigine.

Product ID69102-319_87a84064-9191-4025-bafe-297a6dd86407
NDC69102-319
Product TypeHuman Prescription Drug
Proprietary NameSUBVENITE
Generic NameLamotrigine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2018-03-10
Marketing CategoryANDA / ANDA
Application NumberANDA078947
Labeler NameOWP Pharmaceuticals, Inc.
Substance NameLAMOTRIGINE
Active Ingredient Strength100 mg/1
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Anti-epileptic Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 69102-319-01

100 TABLET in 1 BOTTLE (69102-319-01)
Marketing Start Date2018-03-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69102-319-02 [69102031902]

SUBVENITE TABLET
Marketing CategoryANDA
Application NumberANDA078947
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-03-10

NDC 69102-319-01 [69102031901]

SUBVENITE TABLET
Marketing CategoryANDA
Application NumberANDA078947
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-03-10

Drug Details

Active Ingredients

IngredientStrength
LAMOTRIGINE100 mg/1

OpenFDA Data

SPL SET ID:7ad18b68-ba16-4810-9c3e-27fa970454e8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2001506
  • 2001508
  • 753451
  • 751563
  • 751139
  • 198427
  • 2003796
  • 2003797
  • 2003801
  • 282401
  • 2003798
  • 2003799
  • 198428
  • 198429
  • UPC Code
  • 0369102319022
  • 0369102150069
  • 0369102319015
  • 0369102301027
  • 0369102320011
  • Pharmacological Class

    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Mood Stabilizer [EPC]
    • Anti-epileptic Agent [EPC]

    Medicade Reported Pricing

    69102031901 SUBVENITE 100 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "SUBVENITE" or generic name "Lamotrigine"

    NDCBrand NameGeneric Name
    69102-306SUBVENITESUBVENITE
    69102-301SUBVENITESUBVENITE
    69102-312SUBVENITESUBVENITE
    69102-300SUBVENITESUBVENITE
    69102-150SUBVENITESUBVENITE
    69102-319SUBVENITESUBVENITE
    69102-320SUBVENITESUBVENITE
    70518-2645SUBVENITESUBVENITE
    0093-0039LamotrigineLamotrigine
    0093-0132LamotrigineLamotrigine
    0093-0463LamotrigineLamotrigine
    0093-0688LamotrigineLamotrigine
    0093-7247LamotrigineLamotrigine
    0093-7248LamotrigineLamotrigine
    0115-1526LamotrigineLAMOTRIGINE
    0115-1527LamotrigineLAMOTRIGINE
    0115-1528LamotrigineLAMOTRIGINE
    0115-1529LamotrigineLAMOTRIGINE
    0115-9939LamotrigineLAMOTRIGINE
    0115-9940LamotrigineLAMOTRIGINE
    0115-9941LamotrigineLAMOTRIGINE

    Trademark Results [SUBVENITE]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    SUBVENITE
    SUBVENITE
    87690016 not registered Live/Pending
    OWP Pharmaceuticals, Inc.
    2017-11-17

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.